Trade Names: | |
Synonyms: | |
Status: | Approved (1955) |
Entry Type: | Small molecule |
Molecule Category: | Salt |
UNII: | 4B3SC438HI |
Parent Compound: | METHYLPHENIDATE |
InChI Key | JUMYIBMBTDDLNG-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C14H20ClNO2 |
Molecular Weight | 269.77 |
AlogP | 2.09 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 3.0 |
Polar Surface Area | 38.33 |
Molecular species | BASE |
Aromatic Rings | 1.0 |
Heavy Atoms | 17.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC06 neurotransmitter transporter family
|
- | 20-122 | - | - | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Depressive Disorder | 3 | D003866 | ClinicalTrials |
Fatigue | 3 | D005221 | ClinicalTrials |
Tobacco Use Disorder | 3 | D014029 | ClinicalTrials |
Sleep Wake Disorders | 2 | D012893 | ClinicalTrials |
Neoplasms | 2 | D009369 | ClinicalTrials |
Conduct Disorder | 1 | D019955 | ClinicalTrials |
Multiple Sclerosis, Chronic Progressive | 1 | D020528 | ClinicalTrials |
Multiple Sclerosis, Relapsing-Remitting | 1 | D020529 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 31836 |
ChEMBL | CHEMBL1722 |
EPA CompTox | DTXSID8020886 |
FDA SRS | 4B3SC438HI |
KEGG | D07806 |
SureChEMBL | SCHEMBL41067 |